Anticorps Recombinant de lapin anti-TRPS1

TRPS1 Recombinant Antibody for Cytometric bead array, Sandwich ELISA, Indirect ELISA, Sample test

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

Cytometric bead array, Sandwich ELISA, Indirect ELISA, Sample test

Conjugaison

Non conjugué

CloneNo.

230051G2

N° de cat : 83062-3-PBS

Synonymes

Tricho-rhino-phalangeal syndrome type I protein, LGCR, GC79, 230051G2

---

Galerie de données de validation

• 

  Sandwich ELISA standard curve of MP00096-1

  Sandwich ELISA standard curve of MP00096-1, Human TRPS1 Recombinant Matched Antibody Pair - PBS only. 83062-1-PBS was coated to a plate as the capture antibody and incubated with serial dilutions of standard Ag33959. 83062-3-PBS was HRP conjugated as the detection antibody. Range: 39.1-2500 pg/mL.

• 

  Sample test of MP00096-1

  The mean TRPS1 concentration was determined to be 3.9 ng/mL in HeLa cell extract based on a 1.0 mg/mL extract load and 3.2 ng/mL in U2OS cell extract based on a 3.5 mg/mL extract load.

• 

  Cytometric bead array standard curve of MP00096-1

  Cytometric bead array standard curve of MP00096-1, TRPS1 Recombinant Matched Antibody Pair - PBS only. Capture antibody: 83062-1-PBS. Detection antibody: 83062-3-PBS. Standard: Ag33959. Range: 0.625-20 ng/mL.

---

Informations sur le produit

83062-3-PBS cible TRPS1 dans les applications de Cytometric bead array, Sandwich ELISA, Indirect ELISA, Sample test et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Recombinant
• Type: Anticorps
• Immunogène: TRPS1 Protéine recombinante Ag33959
• Nom complet: trichorhinophalangeal syndrome I
• Masse moléculaire calculée: 1294 aa, 143 kDa
• Numéro d’acquisition GenBank: BC125020
• Symbole du gène: TRPS1
• Identification du gène (NCBI): 7227
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par protéine A
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

{{ptg:RelatedPrimaryAntibodies}}